AOR

The Archives of Ophthalmological Research aims to publish issues related to publish articles of the highest scientific and clinical value at an international level, and accepts articles on these topics. The target audience of the journal included specialists and physicians working in ophthalmology, and other health professionals interested in these fields.

EndNote Style
Index
Case Report
Insights into a rare congenital abnormality: clinical and imaging features of two hiperpigmented torpedo maculopathy cases
Torpedo maculopathy (TM) is a rare congenital, nonprogressive macular anomaly of the retina pigment epithelium(RPE) or choroid. A characteristic feature is its presentation as an isolated, asymptomatic, hypopigmented nevus in the temporal macula, often described as torpedo-shaped. Contrary to what is known, two cases of TM, both hyperpigmented, one located in the fovea, the other located in the temporal macula, and the first case accompanied by a previously unreported posterior subcapsular cataract at a young age, are presented here. These cases, along with others documented in the literature, suggest that TM can present with atypical characteristics and locations. Recognition of these lesions is important in distinguishing them from more malignant diseases such as malignant melanoma, choroidal nevus, congenital hypertrophy of RPE, and congenital toxoplasmosis.


1. Light JG, Alvin Liu TY. A novel phenotype of torpedo maculopathy on spectral-domain optical coherence tomography. Am J Ophthalmol Case Rep. 2020;20:100956. doi:10.1016/j.ajoc.2020.100956
2. Venkatesh R, Jain K, Pereira A, Thirumalesh YNK, Yadav NK. Torpedo retinopathy. J Ophthalmic Vis Res. 2020;15(2):187-194. doi:10.18502/jovr.v15i2.6736
3. Jiao G, Goldburg SR, Breazzano MP, Pandey A. Expanded spectrum torpedo retinopathy: a case series. Case Rep Ophthalmol. 2023;12(14): 209-213. doi:10.1159/000530005
4. Ranjith PC, Giridhar A. Hyperpigmented torpedo maculopathy. Indian J Ophthalmol. 2019;67(2):270-271. doi:10.4103/ijo.IJO_886_18
5. Rohl A and Vance S. Hyperpigmented torpedo maculopathy with Pseudo-Lacuna: a 5-year follow-up. Case Rep Ophthalmol 2016;7:184-190. doi:10.1159/000445497
6. Shirley K, O’Neill M, Gamble R, Ramsey A, McLoone E. Torpedo maculopathy: disease spectrum and associated choroidal neovascularisation in a paediatric population. Eye. 2018;32(8):1315-1320. doi:10.1038/s41433-018-0074-7
7. Shields CL, Guzman JM, Shapiro MJ, Fogel LE, Shields JA. Torpedo maculopathy at the site of the fetal “bulge”. Arch Ophthalmol. 2010; 128(4):499-501. doi:10.1001/archophthalmol.2010.29
8. Yuan H, Dou H, Li X. Multimodal imaging of choroidal structural in torpedo maculopathy. Front. Med. 2023;10:1085457. doi:10.3389/fmed. 2023.1085457
9. Trevino RC, Ridder WH 3rd, Laul A, Hill J. Long-term follow-up of torpedo maculopathy: a case series and mini-review. BMC Ophthalmol. 2024;24(1):5. doi:10.1186/s12886-023-03254-z
10. Wong EN, Fraser-Bell S, Hunyor AP, Chen FK. Novel optical coherence tomography classi?cation of torpedo maculopathy. Clin Exp Ophthalmol. 2015;43(4):342-348. doi:10.1111/ceo.12435
11. Tripathy K, Sarma B, Mazumdar S. Commentary: inner retinal excavation in torpedo maculopathy and proposed type 3 lesions in optical coherence tomography. Indian J Ophthalmol. 2018;66(8):1213-1214. doi:10.4103/ijo.IJO_656_18
12. Richardson RB, Ainsbury EA, Prescott CR, Lovicu FJ. Etiology of posterior subcapsular cataracts based on a review of risk factors including aging, diabetes, and ionizing radiation.Int J Radiat Biol. 2020;96(11):1339-1361. doi:10.1080/09553002.2020.1812759 </ol> <p>
Volume 2, Issue 4, 2025
Page : 75-77
_Footer